Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 260,354 shares of VCEL, which is worth approximately $10.2 Million. The most recent transaction as insider was on Mar 13, 2024, when has been sold 17,500 shares (Common Stock) at a price of $3.02 per share, resulting in proceeds of $52,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

17.84% 3M change

17.94% 12M change

Total Value Held $10.2 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 7.61%	212,370 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$892,237 $49.5 p/Share	18,025 Reduced 8.47%	194,870 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	38,887 Added 16.35%	199,013 Common Stock
Feb 15 2024	SELL Open market or private sale	$854,875 $48.85 p/Share	17,500 Reduced 9.14%	174,008 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 8.37%	191,508 Common Stock
Feb 14 2024	SELL Open market or private sale	$822,325 $46.99 p/Share	17,500 Reduced 9.14%	174,008 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 8.37%	191,508 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$164,879 $47.42 p/Share	3,477 Reduced 1.96%	174,008 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	7,500 Added 4.05%	177,485 Common Stock
Jan 18 2024	SELL Open market or private sale	$645,289 $38.58 p/Share	16,726 Reduced 8.96%	169,985 Common Stock
Jan 18 2024	BUY Exercise of conversion of derivative security	$50,512 $3.02 p/Share	16,726 Added 8.22%	186,711 Common Stock
Jan 17 2024	SELL Open market or private sale	$635,086 $37.97 p/Share	16,726 Reduced 8.96%	169,985 Common Stock
Jan 17 2024	BUY Exercise of conversion of derivative security	$50,512 $3.02 p/Share	16,726 Added 8.22%	186,711 Common Stock
Dec 14 2023	SELL Open market or private sale	$445,439 $37.12 p/Share	12,000 Reduced 6.59%	169,985 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 6.19%	181,985 Common Stock
Dec 13 2023	SELL Bona fide gift	-	6,757 Reduced 3.82%	169,985 Common Stock
Dec 13 2023	SELL Open market or private sale	$408,360 $34.03 p/Share	12,000 Reduced 6.59%	169,985 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 6.19%	181,985 Common Stock
Dec 07 2023	SELL Open market or private sale	$406,080 $33.84 p/Share	12,000 Reduced 6.36%	176,742 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 5.98%	188,742 Common Stock
Dec 06 2023	SELL Open market or private sale	$426,828 $34.43 p/Share	12,397 Reduced 6.55%	176,742 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$44,257 $3.57 p/Share	12,397 Added 6.15%	189,139 Common Stock
Feb 19 2023	SELL Payment of exercise price or tax liability	$123,544 $29.82 p/Share	4,143 Reduced 2.3%	175,808 Common Stock
Feb 19 2023	BUY Exercise of conversion of derivative security	-	8,938 Added 4.73%	179,951 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$161,713 $29.82 p/Share	5,423 Reduced 3.07%	171,013 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare